A-1 Limited Seeks Shareholder Approval for Major Corporate Restructuring and Business Expansion
A1, formerly A-1 Acid Limited, has announced significant corporate actions through a postal ballot notice. The company proposes to increase its authorized share capital from Rs. 20.00 crores to Rs. 46.00 crores, issue a 3:1 bonus share, and split its stock from Rs. 10.00 to Rs. 1.00 face value. A1 also plans to diversify into sports equipment and pharmaceuticals, and increase its stake in its EV subsidiary from 45% to 51% with an investment of up to Rs. 20.00 crores. Shareholders can vote on these proposals from November 22 to December 21, 2025.

*this image is generated using AI for illustrative purposes only.
A1 , formerly known as A-1 Acid Limited, has announced a series of significant corporate actions through a postal ballot notice, seeking shareholder approval for major restructuring and business expansion initiatives. The company's board has proposed several key changes that could substantially alter its capital structure and business focus.
Capital Restructuring
The company has proposed a three-pronged approach to restructure its capital:
Increase in Authorized Share Capital: A1 plans to increase its authorized share capital from Rs. 20.00 crores to Rs. 46.00 crores, preparing the ground for potential future equity issuances.
Bonus Share Issue: The company intends to reward its shareholders with a 3:1 bonus issue, meaning three new fully paid-up equity shares for every one existing share held.
Stock Split: Following the bonus issue, A1 proposes to sub-divide its shares, changing the face value from Rs. 10.00 to Rs. 1.00 per share. This move aims to improve stock liquidity and potentially make the shares more accessible to a broader range of investors.
Business Expansion
In addition to the capital restructuring, A1 is seeking to diversify its business activities:
Sports Equipment Business: The company plans to enter the sports equipment market, focusing on importing, exporting, trading, and distributing various sports-related products.
Pharmaceutical Venture: A1 aims to expand into the pharmaceutical sector, engaging in sourcing, supplying, contract manufacturing, and manufacturing of pharmaceutical products, drug intermediates, and healthcare products for both domestic and international markets.
Investment in Subsidiary
A1 also proposes to increase its stake in its subsidiary, A-1 Sureja Industries, a partnership firm involved in manufacturing battery-operated electric two-wheelers (EVs). The company plans to invest up to Rs. 20.00 crores to increase its shareholding from 45% to 51%, signaling a stronger commitment to the EV sector.
Voting Process
Shareholders can vote on these resolutions through postal ballot or e-voting. The voting period is set from November 22, 2025, to December 21, 2025, with results expected to be announced within 48 hours of the voting conclusion.
These proposed changes, if approved, could significantly impact A1's future growth trajectory and market positioning. Shareholders are advised to carefully consider the implications of these resolutions before casting their votes.
Historical Stock Returns for A1
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.00% | +27.62% | +109.98% | +306.40% | +514.07% | +608.04% |
































